Evaluation of Risk Factors Predictive of Hypothermia in Preterm Neonates in Incubators During the First Week of Life
NCT ID: NCT02803606
Last Updated: 2018-08-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2009-06-30
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management and Thermal Comfort of Premature Infants Under 32 Weeks
NCT03648606
Long Term Prognostic of Neonatal Hypoxic Ischemic Encephalopathy With Hypothermia Treatment
NCT02676063
Air vs. Cutaneous Control Mode for Preterm Infants ≤ 32 WG in Incubators: Impact on Body Growth and Morbidity
NCT03919188
Cardboard Cot in Neonatal Thermoregulation: A Randomized Cross Over Trial
NCT03344978
Preemie Hypothermia for Neonatal Encephalopathy
NCT01793129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hypothermia
Preterm neonates less than 32 weeks of gestational age admitted at birth to the Neonatal Medicine unit
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Birth in one of the two maternity hospitals of Amiens agglomeration (CGO or clinic of Europe )
* Arrived in the Neonatal Medicine unit \< 2 hours of life
* Necessitated a care in an incubator
Exclusion Criteria
* Birth outside the Amiens metropolitan area
* Arrived in the Neonatal Medicine unit after 2 hours of life
* Present a malformation syndrome or severe heart disease
* Pathology requiring support within the first 7 days of life
* Apgar score \< 5 to 10 minutes of life
* Need for initial management in open incubator
* Unavailability of a type of incubator " Caleo® "
25 Weeks
32 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre TOURNEUX, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
CHU Amiens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AOL08-DR-TOURNEUX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.